NEW YORK (TheStreet) -- CHANGE IN RATINGS
Aeropostale (ARO) upgraded to Buy at TheStreet Ratings.
American Eagle (AEO) upgraded to Buy at TheStreet Ratings.
Amphenol (APH) rated new Buy at Keybanc. $55 price target. Company can continue to deliver solid growth, augmented by acquisitions.HomeAway (AWAY) upgraded at Pacific Crest from Sector Perform to Outperform, Pacific Crest said. $31 price target. Company has a large market opportunity. International Rectifier (IRF) upgraded at JMP from Market Perform to Outperform. $25 price target. Sales will likely bottom out in the current quarter. Netflix (NFLX) downgraded at Citigroup from Buy to Neutral. $95 price target. Dramatic ramp up in international expansion and two major execution errors.
STOCK COMMENTS / EPS CHANGESAmerican Eagle (AEO) numbers raised at Goldman. Shares of AEO now seen reaching $18, according to Goldman Sachs. Estimates also increased, given better sales momentum. Buy rating. American Eagle estimates raised at UBS through 2013. Top line is back but concerns remain over margins. Maintain $14 price target and Neutral rating. Aeropostale (ARO) estimates lowered at Oppenheimer through 2012, Oppenheimer said. Failed to meet Thanksgiving expectations. Outperform rating. Avago Technologies (AVGO) estimates lowered at Jefferies through 2012. Downside risk to industrial and wired forecast. Buy rating. Baxter (BAX) estimates, target cut at Morgan Stanley. Shares of BAX now seen reaching $60, according to Morgan Stanley. Estimates also reduced, following recent meetings with management. Buy rating. Express (EXPR) estimates, target boosted at Brean Murray. Shares of EXPR now seen reaching $29, according to Brean Murray. Estimates also upped, as the company has solid merchandising well and is expanding its customer base. Buy rating. Express estimates increased at UBS through 2013. Ability to win on comp and margin. Maintain $26 price target and Buy rating. Finisar (FNSR) estimates lowered at Jefferies through 2012. Quarter slightly below expectations. Buy rating. Guess (GES) numbers lowered at Jefferies. Shares of GES now seen reaching $55. Estimates also lowered on conservative guidance. Buy rating. Guess estimates, target reduced at Sterne Agee. Shares of GES now seen reaching $50. Estimates also cut, to match the company's new guidance. Buy rating. Hospira (HSP) estimates lowered at Citigroup through 2012. Manufacturing issues appear increasingly problematic. Maintain $30 price target and Neutral rating. Johnson Controls (JCI) estimates cut at Morgan Stanley through 2013, Morgan Stanley said. Company is leveraged to weaker macro conditions. Overweight rating and $48 price target. Marathon Petroleum (MPC) estimates increased at Morgan Stanley through 2013. Company held an upbeat analyst meeting, highlighting growth prospects. Overweight rating and $53 price target. Rovi (ROVI) estimates, target reduced at Morgan Stanley. Shares of ROVI now seen reaching $34, according to Morgan Stanley. Estimates also cut, to match the company's new guidance. Equal-weight rating. United Natural Foods (UNFI) target raised at Jefferies. Shares of UNFI now seen reaching $44. Gross margins will begin to stabilize. Buy rating. UnitedHealth Group (UNH) numbers raised at Oppenheimer. UNH estimates raised through 2012, Oppenheimer said. Several growth opportunities will lead to EPS accretion. Perform rating. Yum Brands (YUM) numbers upped at BofA/Merrill. YUM estimates were boosted through 2013. Company will likely see higher sales growth in China. Buy rating and new $67 price target.
STRATEGY CALLS / MARKET CALLSPanasonic (PC) forecast cut at JP Morgan. PC unit sales forecast was reduced because of lower disk-drive supply, according to JP Morgan.
>To submit a news tip, email: firstname.lastname@example.org.
Follow TheStreet on Twitter and become a fan on Facebook.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV